Risk factors for cardiovascular disease in women

Maturitas

Volumn 63, Issue 3, 2009, Pages 186-190

  Schenck Gustafsson, Karin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cardiovascular disease; Coronary heart disease; Gender; Risk factors; Women

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EZETIMIBE; FENOFIBRATE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SEX HORMONE; SIMVASTATIN;

ALCOHOL CONSUMPTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; COUGHING; DIABETES MELLITUS; DYSLIPIDEMIA; EATING HABIT; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; IMMOBILIZATION; KINESIOTHERAPY; MEDITERRANEAN DIET; OBESITY; PERIPHERAL EDEMA; PREVALENCE; REVIEW; SECONDARY PREVENTION; SEX DIFFERENCE; SMOKING; STRESS;

AGE FACTORS; ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIET; DYSLIPIDEMIAS; EXERCISE; FEMALE; HUMANS; HYPERTENSION; OBESITY; RISK FACTORS; SEX FACTORS; SMOKING; STRESS, PSYCHOLOGICAL;

EID: 67649804682     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.02.014     Document Type: Review

References (53)

1. World Health Organization. The World Health Report 2002. Reducing risks, promoting healthy life. World Health Organization: Geneva. www.who.int/whosis/; 2002.
2. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case control study. Lancet 364 (2004) 937-952
3. Anand S.S., Islam S., Rosengren A., et al. Investigators riskfactors of myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 29 7 (2008) 932-940
4. Mosca L., Appel L.J., Benjamin E.J., et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 109 (2007) 672-693
5. Mosca L., Banka C.L., Benjamin E.J., et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 115 11 (2007) 1481-1501
6. Stramba-Badiale M., Fox K.M., Priori S.G., et al. The European Society of Cardiology Policy conference on cardiovascular diseases in women. Eur Heart J 27 8 (2006) 994-1005
7. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837
8. Conroy R.M., Pyorälä K., Fitzgerald A.P., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24 11 (2003) 987-1003 SCORE (Systematic Coronary Risk Evaluation)
9. Ridker P., Buring E.J., Rifai N., et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women. JAMA 297 6 (2007) 6
10. Daly C., Clemens F., Lopez Sendon J.L., et al. Euro Heart Survey investigators: gender differences in the management and clinical outcome of stable angina. Circulation 113 4 (2006) 490-498
11. Kim E.S., Carrigan T.P., and Menon V. Enrollment of women in NHLBI-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion. J Am Coll Cardiol 52 (2008) 672-673
12. Jacobs D.R., Mebane I.L., Bangdiwala S.I., et al. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow up study of the lipid research clinics prevalence study. Am J Epidemiol 131 (1990) 132
13. Nationella Riktlinjer för hjärtsjukvård. Swedish Board of Health and Welfare; 2008.
14. Department of Health. National Service Framework for Coronary Heart Disease. London; 2000.
15. British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK. Primary Care Cardiovascular Society, The Stroke Association JBS 2: Joint British Societies guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91(Suppl. iv):v1-v52.
16. Legato M.J. Dyslipidaemia, gender, and the role of high density lipoprotein cholesterol: implications for therapy. Am J Cardiol 86 12A (2000) 15L
17. Giljohann D.A., Seferos D.S., Prigodich A.E., Patel P.C., and Mirkin C.A. Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc 131 February (6) (2009) 2072-2073
18. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection study of cholesterol lowering with Simvastatin in 20,536 high-risk individuals: a randomised placebo controlled trial. Lancet 360 9326 (2002) 7
19. Lewis S.J., Sacks F.M., Mitchell J.S., et al. Effect of Pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trail. J Am Coll Cardiol 32 1 (1998) 14
20. Aulakh A.K., and Anand S.S. Sex and gender subgroup analyses of randomized trials. Womens Health Issues 17 6 (2007) 342-350
21. Kuoppala J., Lamminpää A., and Pukkala E. Statins and cancer: a systematic review and meta-analysis. Eur J Cancer 44 October (15) (2008) 2122-2132
22. Prospective Studies Collaborations. Age specific relevance of usual blood pressure to vascular mortality: a meta analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002) 1903-1913
23. Van der Giezen A.M., Schopman-Geurts van Kessel J.G., Schouten E.G., et al. Systolic blood pressure and cardiovascular mortality among 13,740 Dutch women. Pre Med 19 (1990) 456
24. Doll R., Peto R., Boreham J., et al. Mortality in relation to smoking: 50 year's observations on male British doctors. BMJ 328 (2004) 1591-1627
25. Petersen S., and Peto V. Smoking statistics (2004), British Heart Foundation, London
26. Sarna L., Bialous S.A., Jun H.J., Wewers M.E., Cooley M.E., and Feskanich D. Smoking trends in the Nurses' Health Study (1976-2003). Nurs Res 57 November-December (6) (2008) 374-382
27. World Health Organization. The World Health Report 2003 reducing risks, promoting healthy life. World Health Organization: Geneva. www.who.int/whosis/; 2002.
28. World Health Organization. The World Health Report 2005. reducing risks, promoting healthy life. World Health Organization: Geneva. www.who.int/whosis/; 2002.
29. Geiss L.S., Herman W.H., and Smith P.J. Mortality in non-insulin dependent diabetes. Diabetes in America/National Diabetes Data Group. 2nd ed. (1995), National Institutes of Health, Bethesda, MD
30. Garcia M.J., Mc Namara P.M., Gordon T., et al. Morbidity and mortality in the Framingham population, sixteen years follow up. Diabetes 23 (1974) 105-111
31. Hu F.B., Stampfer M.J., Solomon C.G., et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow up. Arch Intern Med 161 (2001) 1717
32. Almdal T., Scharling H., Jensen J.S., et al. The independent effect of type 2 diabetes mellitus on ischaemic heart disease, stroke and death: a population based study on 13000 men and women with 20 years follow up. Arch Intern Med 164 (2004) 1422
33. Norhammar A, Stenestrand U, Linbäck J, et al., on behalf of the register of information and knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Heart 2008;94:1565-1570.
34. Manson J.E., Willet W.C., Stampfer M.J., et al. Body weight and mortality among women. N Engl J Med 333 (1995) 677
35. Yarnell J.W., Patterson C.C., Thomas H.F., et al. Central obesity: predictive value of skinfold measurements for subsequent ischaemic heart disease at 14 years follow-up in the Caerphilly Study. J Obes Relat Metab Disord 25 10 (2001) 1546-1549
36. National Institute of health and Clinical Excellence. Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. December 2006.
37. Blair S.N., Kohl H.W., Paffenbarger R.S., et al. Physical fitness and all cause mortality: a prospective study of healthy men and women. JAMA 262 (1989) 2395
38. Bush T.L., Fried L.P., and Barrett-Connor E. Cholesterol, lipoproteins and coronary heart disease in women. Clin Chem 34 (1988) B60
39. Manson J.E., Hu F.B., Rich-Edwards J.W., et al. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med 341 (1999) 650
40. Kurisu S., Sato H., Kawagoe T., et al. Tako-tsubo like left ventricular dysfunction with STsegment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J 143 3 (2002) 448-455
41. Orth-Gomér K., Wamala S.P., Horsten M., et al. Marital stress worsens prognosis in women with coronary heart disease: The Stockholm Female Coronary Risk Study Circulation. JAMA 284 23 (2000) 3008-3014
42. Rosengren A., Hawken S., Ounpuu S., et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 953-962
43. Naqvi T.Z., Naqvi S.S.A., and Bairey Merz N. Gender differences in the link between depression and cardiovascular disease. Psychosomatic Med 67 Suppl. 1 (2005) S15-S28
44. Lindwall-Sundel K., Andersson A., Eriksson I., et al. High frequency of anxiety and angina pectoris in depressed women with coronary heart disease. J Gender Med 4 2 (2007) 146-156
45. Gunzerath L., Faden V., Zakhari S., et al. National Institute on alcohol abuse and alcoholism report on moderate drinking. Alcohol Clin Exp Res 28 6 (2004) 829-847
46. Fagrell B. The benefit of moderate alcohol consumption once again questioned by the Swedish National Institute of Public Health. Läkartidningen 103 44 (2006) 3385-3386
47. Knoops K.T., de Groot L.C., Kromhout D., et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 292 (2004) 1433-1439
48. de Lorgeril M., Renaud S., Mamelle N., et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343 (1994) 1454-1459
49. Singh R.B., Dubnov G., Niaz M.A., et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised singleblind trial. Lancet 360 (2002) 1455-1461
50. Howard B.V., Van Horn L., Hsia J., et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295 (2006) 655-666
51. Rossouw J.E., Prentice R.L., Manson J.E., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297 (2007) 1465-1477
52. Grodstein F., Manson J.E., and Stampfer M.J. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Women's Health 15 (2006) 35-44
53. Løkkegaard E., Andreasen A.H., Jacobsen R.K., et al. Hormone therapy and risk of myocardial infarction: a national register study. Eur Heart J 29 November (21) (2008) 2660-2668